We investigated the antibacterial activity of sub-inhibitory concentrations of ethanolic extract of propolis (EEP), and its effect on the antibacterial activity of some antibiotics. Some clinically isolated Gram-positive strains were used.
Introduction
Propolis (bee glue) is a natural resinous hive product, collected from various plant sources, manipulated by honeybees and extensively used in folk medicine.
Recently it has attracted much attention as a useful substance applied in medicine and cosmetics due to its antibacterial and antifungal activities (Burdock, 1998) .
In general, it is composed of 50% resin and vegetable balsam, 30% wax, 10% essential and aromatic oils, 5% pollen and 5% various other substances, including organic debris depending on the place and time of collection (Nieva Moreno et al., 1999; Sforcin et al., 2000) .
Among constituents with biological activity, flavonoids contribute more than others to the observed effect of propolis (Marcucci, 1995; Burdock, 1998) .
The antibacterial and antifungal properties of propolis have been extensively investigated and, although its chemical composition is linked to the phytogeographic origin, the activity of bee glue has always been reported (Krol et al.,1993; Kujumgiev et al., 1999; Drago et al., 2000) .
On the basis of some recent studies of the antimicrobial properties of some substances containing flavonoids (Marcucci, 1995; Stepanovic et al., 2003) , we have investigated the antimicrobial activity and synergistic effect with some antibiotics of ethanolic extract of propolis (EEP) against 140 Staphylococcus spp. and 123 Streptococcus spp. strains.
At present, specific studies on propolis capacity to inhibit virulence factors are not reported.
We have studied the effect of sub-inhibitory concentrations of EEP on activity of lipase and coagulase enzymes in some Staphylococcus spp. strains and its interaction with the production of biofilm in Staphylococcus aureus ATCC 6538P.
Furthermore, we have investigated for a structural damage of bacterial cells, using propidium iodide (PI) uptake, by fluorescence microscopy.
Materials and methods

Propolis and ethanol extract
Crude propolis (kindly supplied by Specchiasol S.p.A. Verona Italy) (Ricchiuto, 1994) was ground, and 6.6 g of fine powder were extracted with a total 100 ml of ethanol 70%, in a rotary shaker for 7 days at room temperature.
The mixture was centrifuged at 3960g for 15 min (Beckman GP Centrifuge); the pellet was handled in the same way three times and supernatants collected and used as EEP.
Bacterial strains
A total of 263 bacterial clinical isolates were tested: 140 Staphylococcus spp. strains (35 S. aureus, 63 S. epidermidis, 7 S. hominis, 18 S. haemolyticus, 10 S. warnerii, 4 S. capitis, 3 S. auricularis) and 123 Streptococcus spp. strains (59 S. faecalis, 30 S. viridans, 15 S. b-haemolyticus, 19 S. pneumioniae).
Muller Hinton Broth (MHB-Oxoid) overnight cultures were centrifuged at 3960g for 10 min, washed in sterile saline and diluted to an optical density equivalent to 0.5 McFarland (1 Â 10 8 CFU/ml).
Antibiotics
Antibacterial drugs: gentamycin (GENT), streptomycin (STREP), ceftriaxon (CFT), erythromycin (ERIT), vancomycin (VANC), chloramphenicol (CLM), ampicillin (AMP) (Sigma-Aldrich S.r.l.Milano), were dissolved in sterile saline at the concentration of 1 mg/ml.
Minimal inhibitory concentration
Minimal Inhibitory Concentrations (MICs) of EEP and of the antibacterial drugs were determined.
Muller Hinton Agar plates (MHA, Oxoid S.p.A. Milano Italy) were supplemented with 2-fold serial dilutions of EEP at concentrations ranging from 2.5 to 0.1 mg/ml and inoculated with 10 5 CFU by multipoint inoculator.
Ethanol at the concentration used did not interfere with bacterial growth.
Two-fold serial dilutions of each antibiotic in a range from 200 to 0.1 mg/ml were added to MHA and MHA+EEP plates (1/2 EEP MIC for each tested strain).
The plates were incubated at 37 1C for 24 h.
The MIC values were defined as the lowest concentration inhibiting completely the bacterial growth.
Lipase test
Eighteen Sthaphylococcus spp. strains grown overnight in Brain Heart Infusion (BHI, Oxoid) (condition C 1 ) and BHI+ EEP at 1/2 MIC for each strain (condition C 2 ), were centrifuged at 3960g, washed two times in PBS. Compared at the same OD 600 and 1 Â 10 5 CFU were inoculated
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into Spirit Blue Agar (SBA, Difco) normal and added with 1/2 MIC value of EEP. To improve sizing of lipase halos, the lipolytic activity of the strains, was tested under the same experimental conditions, in a medium without Blue Spirit dye.
The lipolytic activity of strains was detected after 18 h of growth at 37 1C.
The inhibition of enzymatic activity was considered total when the halo was absent and partial when the halo diameter was o50%, compared with the positive control without EEP.
Coagulase test
The generally accepted identifying characteristic of S. aureus is the ability to produce free and bound coagulase. The coagulase test detects the presence of clumping factor through clumping of fibrinogensensitized sheep red blood cells (Flandrois and Carret, 1981) .
The specificity of the reaction is ensured by a simultaneous test with a control reagent.
Coagulase activity of 11 S. aureus, at subinhibitory concentrations of EEP, was estimated by the Staphylase test Kit DR595 (Oxoid).
Propidium iodide uptake
Overnight BHI brothcultures of S. aureus ATCC 25923 and of S. aureus 408 (clinical isolates), were grown at mid log phase and despensed in equal volume into two vials.
One of these was supplemented with EEP at 1/2 MIC value for each strain for 45 min at 25 1C, successively 0.05 ml of both samples were transferred into Eppendorf vials containing 0.95 ml of phosphate buffer.
Five microliters of staining solution, consisting of 1 mg/ml PI dissolved in 50 mM phosphate buffer pH ¼ 6, were added to Eppendorf vials.
After 15 min at 25 1C the staining solution was removed by centrifuging for 1 min at 3960g and the pellet was dissolved in 0.1 ml phosphate buffer.
The cells were then examined under a fluorescence microscope (Leitz Aristoplan Â 400, Leitz S.r.l. Milano Italy).
The presence of fluorescent cells was compared to the control.
Prevention of biofilm forming by EEP
Adherence to smooth surfaces was performed using the modified Christensen method (Christensen et al., 1982) .
Twenty-four-well tissue cultures plates containing Luria-Bertani broth (LB) and LB+EEP at 1/2, 1/4, 1/8 MIC values were incubated with S. aureus ATCC 6538P with overnight broth culture (200 ml).
The adherence was measured after 48 h of incubation at 37 1C.
After aspiration of the supernatants, the wells were washed four times with PBS (pH ¼ 7.2) and stained with safranin for 10 min.
After various washing in PBS, the staining retained by biofilm was extracted with ethanol and measured by spectrophotometer (DU70 Beckman) at 484 nm. 
Results
MICs of ethanolic extracts of propolis (EEP)
MIC
Minimal inhibitory concentrations
For most antibiotics, a clear abatement of MIC 50 and MIC 90 of 140 strains of Staphylococcus spp. was evident in presence of EEP (Table 2) .
Especially for STREP, CLM, AMP, GENT, the presence of EEP enhanced the antimicrobial effect of these antibiotics. The best performance was detected with S. aureus in which in presence of STREP+EEP, lost their characteristics of resistance decreasing MIC 90 from 200 to 0.05 mg/ml ( Table 2) .
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The association of AMP+EEP, in the same strains, decreased MIC 90 256-fold in S. aureus; 250-fold in S. epidermidis; 132-fold in other Staphylococcus spp.
Also, in this case, in presence of EEP, especially in S. aureus, strains lost their characteristics of resistance.
Synergistic effect appeared also in the association of GENT+EEP in which MIC 90 decreased 263-fold in S. aureus and 132-fold in S. epidermidis.
A moderate effect has been detected in CLM+EEP association ( Table 2) .
The antibiotic VANC was the more efficacious drug against Staphylococcus and Streptococcus spp. than the others antibiotics we used.
In fact, MICs of VANC were between 3.12 and 6.25 mg/ml in Staphylococcus spp. and 3.12 mg/ml in Streptococcus spp.
The association of VANC+EEP decreased MIC 90 8-fold in S. aureus and 16-fold in Staphylococcus spp.
In the 64 strains of Streptococcus spp. MIC 90 of STREP+EEP and MIC 90 of GENT+EEP in all strains were reduced 16-fold.
MIC 90 with AMP+EEP were reduced 16-fold in 59 strains of Streptococcus faecalis and 32-fold in remaining Streptococcus spp. (Table 3) .
Neither synergism has been detected with ERIT and CFT in association with EEP, nor in the Staphylococcus spp. (data not shown).
Lipase test
Lipolytic halos, surrounding colonies of 18 strains of Staphylococcus spp. have been compared.
In presence of EEP, especially when EEP was continually present in all stage (condition C 2 : SBA+EEP), small and faint halos displayed an evident decrease in lipase activity (Fig. 1) .
High levels of lipase activity were detected in clinic isolates and in S. aureus ATCC 25923.
Lipase activity for each strain was displayed by halos (Fig. 1) .
The ratio of diameter of halos without and with EEP pointed out an inhibition of lipase activity between 17% and 50% in tested strains (Table 4) .
Coagulase test
In presence of EEP we observed drastic inhibition of coagulase enzyme and using Staphylase test Kit (Oxoid S.p.A) no activity was detected.
Propidium iodide test
An evident suffering state of the cells was evidenced by PI in presence of sub-inhibitory concentrations of EEP. In contrast, in absence of EEP strains of Staphylococcus spp. were always negative to the test (Fig. 2) .
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EEP interference with biofilm production
Adding serial dilutions of sub-inhibitory concentrations of EEP in different wells, a proportional decrease of adhesion in S. aureus ATCC 6538P, was displayed ( Fig. 3) , demonstrating a positive correlation between EEP concentration and adhesion.
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A maximum decrease of 40% in adhesion, and possibly biofilm formation, in presence of EEP at 1/ 2 MIC value was observed.
Discussion
The positive effect of natural propolis is well known. (Kujumgiev et al., 1999; Nieva Moreno et al., 1999; Sforcin et al., 2000) .
Investigating the antimicrobial activity towards some Gram-positive bacteria, we found propolis to be effective against many virulence factors.
Worthy of notice, these multifactorial aspects have been investigated. Sub-inhibitory concentrations of EEP displayed a synergistic effect with many antibiotics we used; an evident decrease of MICs in some drugs is of remarkable interest.
Some components present in propolis extract, like flavonoids (quercetin, galangin, pinocembrin) and caffeic acid, benzoic acid, cinnamic acid, probably act on the microbial membrane or cell wall site, causing functional and structural damages (Marcucci, 1995; Cook and Samman, 1996; Mirzoeva et al.,1997; Gatto et al., 2002) .
As shown by the PI test, a suffering state of the cells in presence of EEP was evident.
Staphylococcus's virulence factor coagulase was completely suppressed by EEP; lipase, for many Staphylococci was strongly reduced and a dosedependent prevention of biofilm formation was evident.
As highlighted in many recent works, the reduction of microbial virulence factors is a target of great interest.
Our observations demonstrate a multiple action of propolis against different virulence factors of some Gram-positive bacteria of clinical interest.
Ineffective antibacterial drugs, consequence of emergence of antibiotic resistances, can be reused at the same time with propolis during early stages of infection. The recovery of efficacy of old antibiotics and consequent reduction of economical problems, are important aspects to be considered.
Although it is highlighted, in vitro and in vivo, the property of propolis as a natural treatment in some Gram-positive infections, no in vivo observations of synergism of propolis and antibiotics are reported.
Our data together with the widespread appearance of antibiotic resistance and the increasing interest towards natural therapy, effective and healthy pharmacological compounds, suggest further studies for best comprehension of which propolis compounds are involved in the mechanisms of synergistic interaction with other antibacterial drugs.
